PER-094-03已完成未知
MULTINATIONAL, PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND STUDY TO INVESTIGATE THE EFFECTIVENESS AND SECURITY OF THE INTRAVENOUS / ORAL SEQUENTIAL MOXIFLOXACINE COMPARED WITH INTRAVENOUS CEFTRIAXONE MORE INTRAVENOUS LEVOFLOXACINE FOLLOWED BY ORAL LEVOFLOXACIN, IN THE TREATMENT OF PATIENTS WITH SEVERE PNEUMONIA ACQUIRED IN THE COMMUNITY.
BAYER S.A.,0 个研究点目标入组 0 人开始时间: 2003年12月31日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients 18 years of age or older.
- •All the signs and symptoms of pneumonia.
- •Fine Score> 71
- •Informed written consent obtained from the patient or legal representative.
排除标准
- •Known hypersensitivity to fluoroquinolones, or other quinolones, and / or to beta-lactams, and / or to macrolide antibiotic medications.
- •Female patients who are pregnant or breastfeeding.
- •Antecedents of disease / tendon alteration related to treatment with fluroquinolones.
研究者
相似试验
已完成
不适用
Comparative Study to Evaluate the Efficacy and Safety of Telithromycin Given Once Daily Versus Cefuroxime Axetil Given Twice Daily in Children With Middle Ear Infections-H669 Otitis media, unspecifiedOtitis media, unspecifiedH669PER-027-05AVENTIS PHARMA S.A.,
进行中（未招募）
不适用
Multinational, prospective, randomized, double-blind, placebo-controlled, parallel groups study to assess the efficacy and safety of Prostaglandin E1 in subjects with circulatory disturbance of a limb - ESPECIAEUCTR2005-001970-29-CZSchwarz Pharma Deutschland GmbH500
已完成
3 期
A Clinical Trial to Assess the effect of Tegoprazan in patients with Erosive Gastroesophageal Reflux DiseaseCTRI/2023/11/059403Dr. Reddy’s Laboratories Ltd.
未知
不适用
A MULTI-NATIONAL, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 3-PERIOD CROSSOVER STUDY WITH GSK 573719 AS MONOTHERAPY IN ADULT SUBJECTS WITH ASTHMAPER-045-12GlaxoSmithKline,87
进行中（未招募）
不适用
Randomized, multinational, multicenter, double-blind, placebo-controlled, two-armparallel group trial of rimonabant 20 mg OD for reducing the risk of majorcardiovascular events in abdominally obese patients with clustering risk factors - CRESCENDOPatients with abdominal obesity at increased risk for cardiovascular events (myocardial infarctio, stroke and cardiovascular death)MedDRA version: 8.0Level: LLTClassification code 10051615EUCTR2005-002942-20-ATSanofi-Synthelabo Recherche17,000